Mandate

Vinge advises wpd in connection with the sale of the wind farm Aldermyrberget

May 16, 2022 Banking and Finance M&A

Vinge advises wpd Europe GmbH, an developer and operator of onshore and offshore wind farms and solar parks, in connection with the sale of the wind farm Aldermyrberget to EB Renewable Energy Fund Europe and LHI Green Infrastructure Invest II.

The wind farm Aldermyrberget consists of 17 wind turbines supplied by the manufacturer Vestas. With a projected energy production of approx. 275 GWh and an annual CO2 reduction of 1.308t, the project actively contributes to sustainable energy supply in Sweden.

Vinge's team primarily consisted of Peter Sundgren, Linus Adolfsson (M&A) and Linn Adelwald (Banking and Finance).

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024